Kaarli Eichhorn

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

By Sujai Shivakumar, Charles Wessner, and Julie Heng For years, China has played a leading role in manufacturing active pharmaceutical ingredients and generic drugs. While securing the supply chain for active pharmaceutical ingredients is increasingly recognized as a national security priority by policymakers, China’s growing role in biotechnological innovation has
Read More

Explainer: A Brief History of the International IP Regime

By Julie Heng, Arrizka Faida, and Chris Borges In a globalized economy, businesses rely on rules protecting intellectual property (IP) to safeguard their ideas and products against counterfeiting, piracy, and theft and to forge international partnerships. To this end, the United States and its partners have long invested in a system of multilateral treaties and international
Read More

ChinaTalk: Innovation Emergency with Trump 1.0’s Patent Director

On February 19th, CSIS Senior Adviser Andrei Iancu appeared on the ChinaTalk podcast to discuss how patents influence emerging technology innovation, how far AI and DOGE could push the current U.S. IP regime, if it matters that China issues more patents than the United States, and more. Listen to the
Read More